PM
PCRX icon

Parametrica Management’s Pacira BioSciences PCRX Stock Holding History

Parametrica Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,249
Closed -$275K – 141
2020
Q2 		$275K Buy
+5,249
New +$219K 0.3% 86
2019
Q1 		– Sell
-6,398
Closed -$275K – 277
2018
Q4 		$275K Buy
6,398
+1,138
+22% +$53.1K 0.34% 147
2018
Q3 		$259K Buy
+5,260
New +$227K 0.57% 86
2016
Q3 		– Sell
-10,035
Closed -$338K – 211
2016
Q2 		$338K Buy
+10,035
New +$493K 0.51% 70
2016
Q1 		– Sell
-4,231
Closed -$325K – 121
2015
Q4 		$325K Sell
4,231
-1,886
-31% -$107K 2.14% 14
2015
Q3 		$251K Buy
+6,117
New +$375K 1.58% 27
2014
Q4 		– Sell
-2,425
Closed -$235K – 69
2014
Q3 		$235K Buy
+2,425
New +$236K 1.37% 35

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return